See more : Enea AB (publ) (0RP6.L) Income Statement Analysis – Financial Results
Complete financial analysis of The Beauty Health Company (SKIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Beauty Health Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- P/F Bakkafrost (BAKKA.OL) Income Statement Analysis – Financial Results
- Housing and Urban Development Corporation Limited (HUDCO.BO) Income Statement Analysis – Financial Results
- Ampco-Pittsburgh Corporation (AP) Income Statement Analysis – Financial Results
- Beijing Centergate Technologies (holding) Co., Ltd. (000931.SZ) Income Statement Analysis – Financial Results
- Federal Home Loan Mortgage Corporation (FMCCP) Income Statement Analysis – Financial Results
The Beauty Health Company (SKIN)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.beautyhealth.com
About The Beauty Health Company
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 397.99M | 365.88M | 260.09M | 119.09M | 166.62M | 112.31M |
| Cost of Revenue | 242.88M | 115.54M | 78.26M | 51.89M | 60.11M | 39.34M |
| Gross Profit | 155.11M | 250.34M | 181.83M | 67.20M | 106.51M | 72.98M |
| Gross Profit Ratio | 38.97% | 68.42% | 69.91% | 56.43% | 63.92% | 64.98% |
| Research & Development | 10.10M | 8.44M | 8.20M | 3.41M | 4.61M | 2.40M |
| General & Administrative | 131.43M | 106.10M | 98.69M | 30.65M | 26.66M | 17.77M |
| Selling & Marketing | 144.50M | 160.08M | 111.58M | 50.32M | 61.77M | 42.74M |
| SG&A | 275.93M | 266.18M | 210.27M | 80.97M | 88.44M | 60.51M |
| Other Expenses | 0.00 | -1.65M | -51.55M | -47.00K | 535.00K | -9.00K |
| Operating Expenses | 286.03M | 274.62M | 218.47M | 84.38M | 93.05M | 62.92M |
| Cost & Expenses | 528.91M | 390.16M | 296.73M | 136.27M | 153.16M | 102.25M |
| Interest Income | 23.17M | 9.18M | 39.00K | 21.28M | 17.09M | 0.00 |
| Interest Expense | 13.65M | 13.39M | 11.78M | 21.28M | 17.09M | 10.05M |
| Depreciation & Amortization | 34.68M | 22.02M | 21.14M | 14.40M | 13.74M | 11.50M |
| EBITDA | -56.00M | 80.75M | -344.44M | -2.81M | 27.90M | 21.56M |
| EBITDA Ratio | -14.07% | -4.58% | -33.91% | -2.37% | 16.73% | 19.19% |
| Operating Income | -130.92M | -24.28M | -36.64M | -17.18M | 13.46M | 10.06M |
| Operating Income Ratio | -32.89% | -6.64% | -14.09% | -14.43% | 8.08% | 8.96% |
| Total Other Income/Expenses | 29.03M | 71.18M | -337.42M | -21.30M | -16.40M | -10.05M |
| Income Before Tax | -101.89M | 45.03M | -377.35M | -38.48M | -2.94M | 10.00K |
| Income Before Tax Ratio | -25.60% | 12.31% | -145.09% | -32.31% | -1.76% | 0.01% |
| Income Tax Expense | -1.77M | 648.00K | -2.24M | -9.31M | -1.30M | 327.00K |
| Net Income | -100.12M | 44.22M | -375.11M | -29.18M | -1.64M | -317.00K |
| Net Income Ratio | -25.16% | 12.09% | -144.22% | -24.50% | -0.98% | -0.28% |
| EPS | -0.76 | 0.30 | -3.67 | -0.85 | -0.05 | 0.00 |
| EPS Diluted | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | 0.00 |
| Weighted Avg Shares Out | 131.68M | 147.55M | 102.11M | 34.29M | 32.14M | 125.40M |
| Weighted Avg Shares Out (Dil) | 131.68M | 148.51M | 102.11M | 34.29M | 32.14M | 125.40M |
Compared to Estimates, Beauty Health (SKIN) Q2 Earnings: A Look at Key Metrics
BeautyHealth to Report Second Quarter 2024 Financial Results on August 8, 2024
e.l.f. SKIN Debuts “Peculiar Behavior” Campaign Starring Jameela Jamil as Highly Requested Bronzing Drops Land at Retailers Globally
The Beauty Health Company (SKIN) Q1 2024 Earnings Call Transcript
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
BeautyHealth Reports First Quarter 2024 Financial Results
BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024
BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer
The Beauty Health Company: A Turnaround Post Earnings?
Source: https://incomestatements.info
Category: Stock Reports